<DOC>
	<DOCNO>NCT02121314</DOCNO>
	<brief_summary>WHO recommend take TB drug fast : TB drug take food , perhaps drug concentration low ; hand : tolerate , drug could also take food . Do low drug concentration - improve adherence therapy - outweigh disadvantage low drug blood concentration time ? How exactly drug concentration time ( pharmacokinetics ) compare fast feed condition , especially early stage TB treatment patient relatively sick , relatively poorly tolerate TB drug ?</brief_summary>
	<brief_title>HRZE Fasted/Fed Newly Diagnosed TB</brief_title>
	<detailed_description>To evaluate influence concomitant food ingestion pharmacokinetics HRZE newly diagnose TB patient To evaluate influence early disease PK parameter HRZE TB patient To compare pharmacokinetics HRZE early stage disease pharmacokinetics HRZE stable condition newly diagnose TB patient To evaluate adverse event HRZE TB patient</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>Patients TB start HRZE therapy Age &gt; 18 year old Written inform consent Use antacid , discontinue study day Active , unstable hepatic disease ( jaundice , HRZ )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>TB</keyword>
	<keyword>bioavailability</keyword>
	<keyword>HRZE</keyword>
	<keyword>fast</keyword>
	<keyword>fed</keyword>
</DOC>